These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. King CH; Creger RJ; Ellner JJ Antimicrob Agents Chemother; 1985 Mar; 27(3):285-90. PubMed ID: 3994344 [TBL] [Abstract][Full Text] [Related]
47. Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen. Kamel Mohamed OH; Wahba IM; Watnick S; Earle SB; Bennett WM; Ayres JW; Munar MY Clin J Am Soc Nephrol; 2007 Jul; 2(4):694-9. PubMed ID: 17699484 [TBL] [Abstract][Full Text] [Related]
48. Predictability of blood levels of gentamicin in man. Barza M; Brown RB; Shen D; Gibaldi M; Weinstein L J Infect Dis; 1975 Aug; 132(2):165-74. PubMed ID: 808583 [TBL] [Abstract][Full Text] [Related]
49. Disposition of Dibekacin in patients undergoing haemodialysis. Campillo JA; Lanao JM; Dominguez-Gil A; Rubio F; Martin A Eur J Clin Pharmacol; 1980 Oct; 18(4):347-50. PubMed ID: 7439256 [TBL] [Abstract][Full Text] [Related]
50. [The role of the phenomenon of the redistribution of aminoglycosides in their monitoring and dosage calculation in patients in the terminal stage of kidney failure undergoing systematic hemodialysis treatment]. Siniukhin VN; Darenkov AF; Stetsiuk EA; Nikolaeva NP; Iarmolinskiĭ IS Urol Nefrol (Mosk); 1991; (1):43-7. PubMed ID: 1858206 [TBL] [Abstract][Full Text] [Related]
51. The determination of aminoglycoside antibiotics in serum: a comparison of a high performance liquid chromatographic method with a microbiological assay. Barends DM; Rutgers A; Van Klingeren B; Hulshoff A Pharm Weekbl Sci; 1982 Aug; 4(4):104-11. PubMed ID: 7133959 [TBL] [Abstract][Full Text] [Related]
52. Initial aminoglycoside levels in the critically ill. Summer WR; Michael JR; Lipsky JJ Crit Care Med; 1983 Dec; 11(12):948-50. PubMed ID: 6641254 [TBL] [Abstract][Full Text] [Related]
53. Aminoglycoside monitoring: timing of peak levels is critical. Blaser J; Simmen HP; Gonzenbach HR; Sonnabend W; Lüthy R Ther Drug Monit; 1985; 7(3):303-7. PubMed ID: 4049468 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of gentamicin and kanamycin during hemodialysis. Danish M; Schultz R; Jusko WJ Antimicrob Agents Chemother; 1974 Dec; 6(6):841-7. PubMed ID: 4451356 [TBL] [Abstract][Full Text] [Related]
55. Gentamicin and tobramycin in patients with various infections--nephrotoxicity. Kahlmeter G; Hallberg T; Kamme C J Antimicrob Chemother; 1978 May; 4 Suppl A():47-52. PubMed ID: 659349 [No Abstract] [Full Text] [Related]
56. Some aspects of aminoglycoside antibiotic measurement. Botha P; Berman PA; Elisha G; Callanan JJ S Afr Med J; 1979 Aug; 56(6):211-3. PubMed ID: 550471 [TBL] [Abstract][Full Text] [Related]
57. Stability of dilute solutions of gentamicin and tobramycin. Josephson L; Houle P; Haggerty M Clin Chem; 1979 Feb; 25(2):298-300. PubMed ID: 759023 [TBL] [Abstract][Full Text] [Related]
58. Aminoglycoside forecasting in neutropenic patients with cancer. Kosirog JL; Rospond RM; Destache C; Hall P Clin Pharmacokinet; 1993 Jan; 24(1):79-87. PubMed ID: 8448975 [TBL] [Abstract][Full Text] [Related]
59. Development and implementation of simplified aminoglycoside empiric dosing guidelines. Reesor Nimmo C; Mamdani F; Baker A; Jewesson P Pharmacotherapy; 1993; 13(4):408-14. PubMed ID: 8361871 [TBL] [Abstract][Full Text] [Related]
60. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis. Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]